BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34741085)

  • 1. Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction.
    Kubota M; Yoshida Y; Kobayashi E; Matsutani T; Li SY; Zhang BS; Mine S; Machida T; Takizawa H; Hiwasa T; Iwadate Y
    Sci Rep; 2021 Nov; 11(1):21772. PubMed ID: 34741085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction.
    Wang H; Lu H; Zhang XM; Goto KI; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Iwadate Y; Mine S; Machida T; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kamitsukasa I; Wada T; Aotsuka A; Sugimoto K; Takizawa H; Kashiwado K; Shin H; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Xu A; Hiwasa T
    BMC Neurol; 2021 Jul; 21(1):274. PubMed ID: 34243715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of Serum CD147 Level in Patients with Transient Ischemic Attack and CD147 Expression in Atherosclerotic Plaque.
    Xu B; Wu C; Wu W; Tan Y; Sun N; Cui J; Lu S; Wang J; Cen S
    J Cardiovasc Transl Res; 2018 Aug; 11(4):285-291. PubMed ID: 30039437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral Th17/Treg imbalance in patients with atherosclerotic cerebral infarction.
    Li Q; Wang Y; Yu F; Wang YM; Zhang C; Hu C; Wu Z; Xu X; Hu S
    Int J Clin Exp Pathol; 2013; 6(6):1015-27. PubMed ID: 23696918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction.
    Wang H; Zhang XM; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Kimura R; Mine S; Kamitsukasa I; Wada T; Aotsuka A; Yoshida Y; Kobayashi E; Matsutani T; Iwadate Y; Sugimoto K; Mori M; Uzawa A; Muto M; Kuwabara S; Takemoto M; Kobayashi K; Kawamura H; Ishibashi R; Yokote K; Ohno M; Chen PM; Nishi E; Ono K; Kimura T; Machida T; Takizawa H; Kashiwado K; Shimada H; Ito M; Goto KI; Iwase K; Ashino H; Taira A; Arita E; Takiguchi M; Hiwasa T
    Oncotarget; 2018 Jan; 9(5):5600-5613. PubMed ID: 29464021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.
    Zhang BS; Zhang XM; Ito M; Yajima S; Yoshida K; Ohno M; Nishi E; Wang H; Li SY; Kubota M; Yoshida Y; Matsutani T; Mine S; Machida T; Takemoto M; Yamagata H; Hayashi A; Yokote K; Kobayashi Y; Takizawa H; Kuroda H; Shimada H; Iwadate Y; Hiwasa T
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of Autoantibody in Patients with Ischemic Stroke.
    Yoshida Y; Hiwasa T; Machida T; Kobayashi E; Mine S; Matsushima J; Takiguchi M; Iwadate Y
    Neurol Med Chir (Tokyo); 2018 Jul; 58(7):303-310. PubMed ID: 29848906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.
    Hiwasa T; Wang H; Goto KI; Mine S; Machida T; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kunimatsu M; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Muto M; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Hattori A; Yamamoto M; Maezawa Y; Kobayashi K; Ishibashi R; Takemoto M; Yokote K; Takizawa H; Kishimoto T; Matsushita K; Kobayashi S; Nomura F; Arasawa T; Kagaya A; Maruyama T; Matsubara H; Tomiita M; Hamanaka S; Imai Y; Nakagawa T; Kato N; Terada J; Matsumura T; Katsumata Y; Naito A; Tanabe N; Sakao S; Tatsumi K; Ito M; Shiratori F; Sumazaki M; Yajima S; Shimada H; Shirouzu M; Yokoyama S; Kudo T; Doi H; Iwase K; Ashino H; Li SY; Kubota M; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Iwadate Y
    BMC Med; 2021 Jun; 19(1):131. PubMed ID: 34103026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases.
    Yoshida Y; Zhang XM; Wang H; Machida T; Mine S; Kobayashi E; Adachi A; Matsutani T; Kamitsukasa I; Wada T; Aotsuka A; Iwase K; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Takizawa H; Kashiwado K; Shin H; Akaogi Y; Shimada J; Nishi E; Ohno M; Takemoto M; Yokote K; Kitamura K; Iwadate Y; Hiwasa T
    Heliyon; 2020 Aug; 6(8):e04661. PubMed ID: 32904265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack.
    Yoshida Y; Wang H; Hiwasa T; Machida T; Kobayashi E; Mine S; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Takizawa H; Kashiwado K; Kamitsukasa I; Shin H; Wada T; Aotsuka A; Nishi E; Ohno M; Takemoto M; Yokote K; Takahashi S; Matsushima J; Zhang XM; Takiguchi M; Iwadate Y
    Oncotarget; 2018 Feb; 9(10):8836-8848. PubMed ID: 29507658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of anti-annexin V antibody in acute cerebral ischemia.
    Lee KO; Kim WJ; Na SJ; Heo JH; Lee KY
    J Neurol Sci; 2011 Jun; 305(1-2):53-6. PubMed ID: 21450308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.
    Li SY; Yoshida Y; Kobayashi E; Kubota M; Matsutani T; Mine S; Machida T; Maezawa Y; Takemoto M; Yokote K; Kobayashi Y; Takizawa H; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kobayashi S; Matsushita K; Nomura F; Matsubara H; Sumazaki M; Ito M; Yajima S; Shimada H; Iwase K; Ashino H; Wang H; Goto K; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Iwadate Y; Hiwasa T
    Sci Rep; 2021 Jun; 11(1):13450. PubMed ID: 34188129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.
    Namiki T; Takemoto M; Hayashi A; Yamagata H; Ishikawa T; Yokote K; Li SY; Kubota M; Zhang BS; Yoshida Y; Matsutani T; Mine S; Machida T; Kobayashi Y; Terada J; Naito A; Tatsumi K; Takizawa H; Nakamura R; Kuroda H; Iwadate Y; Hiwasa T
    BMC Endocr Disord; 2023 Oct; 23(1):239. PubMed ID: 37904164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease.
    Kubota M; Zhang BS; Li SY; Yoshida Y; Wang H; Adachi A; Matsutani T; Mine S; Machida T; Kamitsukasa I; Wada T; Aotsuka A; Kitamura K; Takizawa H; Kuroda H; Iwadate Y; Hiwasa T
    Med Int (Lond); 2023; 3(1):4. PubMed ID: 36699658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke.
    Dambinova SA; Khounteev GA; Izykenova GA; Zavolokov IG; Ilyukhina AY; Skoromets AA
    Clin Chem; 2003 Oct; 49(10):1752-62. PubMed ID: 14500616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.
    Li SY; Yoshida Y; Kobayashi E; Adachi A; Hirono S; Matsutani T; Mine S; Machida T; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Kitamura K; Sumazaki M; Ito M; Shimada H; Takizawa H; Kashiwado K; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Zhang XM; Wang H; Goto K; Iwadate Y; Hiwasa T
    Int J Mol Med; 2020 Oct; 46(4):1274-1288. PubMed ID: 32945427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Ischemic Stroke and Transient Ischemic Attack.
    Skarpengland T; Skjelland M; Kong XY; Skagen K; Holm S; Otterdal K; Dahl CP; Krohg-Sørensen K; Sagen EL; Bjerkeli V; Aamodt AH; Abbas A; Gregersen I; Aukrust P; Halvorsen B; Dahl TB
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29330254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of inflammatory markers with cerebral vasoreactivity and carotid atherosclerosis in transient ischaemic attack.
    Martinic-Popovic I; Simundic AM; Dukic L; Lovrencic-Huzjan A; Popovic A; Seric V; Basic-Kes V; Demarin V
    Clin Biochem; 2014 Nov; 47(16-17):182-6. PubMed ID: 25046654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carotid artery atherosclerotic profile as a predictor of the aorta atherosclerotic profile in patients with cerebrovascular events.
    Hueb JC; Bazan R; Pereira Braga G; Fusco DR; Zanati Bazan SG; Bojikian Matsubara B
    Cerebrovasc Dis; 2013; 36(1):26-32. PubMed ID: 23920380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostatic markers in patients at risk of cerebral ischemia.
    Côté R; Wolfson C; Solymoss S; Mackey A; Leclerc JR; Simard D; Rouah F; Bourque F; Léger B
    Stroke; 2000 Aug; 31(8):1856-62. PubMed ID: 10926947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.